Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Lorenzo BelloAndreas Bikfalvi

Abstract

We investigated the ability of the combinatorial administration of different inhibitors with activities on glioma angiogenesis, migration, and proliferation to produce a prolonged inhibition of glioma growth. We combined inhibitors affecting solely tumor angiogenesis (PF-4/CTF, cyclo-VEGI) or inhibitors affecting both angiogenesis and invasion together (PEX, PF-4/DLR). When administered in combination, these drugs produced a prolonged and increased inhibition of glioma growth independently from the type of inhibitor used. The combinatory administration was more effective than the administration of a single inhibitor alone, and a strong therapeutic response was reached with a significantly lower amount of protein. The strongest inhibition was observed when human PEX and PF-4/DLR, which affect both glioma angiogenesis and invasion by separate mechanisms, were combined. This supports the concept that prolonged glioma growth inhibition can be achieved by simultaneous delivery of molecules that target both tumor and endothelial cells and acting by separate mechanisms.

References

May 1, 1997·Current Opinion in Oncology·R BjerkvigK Edvardsen
May 9, 2000·Critical Reviews in Oncology/hematology·M Hagedorn, A Bikfalvi
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M HagedornA Bikfalvi
Apr 6, 2001·The American Journal of Pathology·J L YuB L Coomber
Apr 20, 2001·The International Journal of Biochemistry & Cell Biology·Y Cao
Oct 18, 2002·Trends in Molecular Medicine·Sophie JaverzatAndreas Bikfalvi
Nov 30, 2002·Trends in Pharmacological Sciences·Andreas Bikfalvi, Roy Bicknell
Dec 21, 2002·Differentiation; Research in Biological Diversity·Joanne L YuR S Kerbel
May 2, 2003·Nature Reviews. Cancer·Peter Friedl, Katarina Wolf
May 3, 2003·Cancer Cell·Selma PennacchiettiPaolo M Comoglio
Jul 2, 2003·Nature Reviews. Cancer·Jasti S Rao
Jul 2, 2003·Nature Medicine·Patricia S Steeg
Jul 3, 2003·The Journal of Biological Chemistry·Lior ZilberbergAndreas Bikfalvi

❮ Previous
Next ❯

Citations

Jun 2, 2005·Nature Reviews. Cancer·Dario Neri, Roy Bicknell
Apr 16, 2009·Cancer Research·Elaine L BearerVittorio Cristini
Jul 26, 2012·Journal of Signal Transduction·Valentina CeaChiara Verpelli
Sep 30, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lei WangWang-Qing Liu
Sep 8, 2010·Bone·Damian C GenetosClare E Yellowley
Mar 23, 2010·Journal of Theoretical Biology·Hermann B FrieboesVittorio Cristini
May 4, 2007·NeuroImage·Hermann B FrieboesVittorio Cristini
Jan 24, 2007·Journal of Theoretical Biology·Paul Macklin, John Lowengrub
Jan 5, 2006·Brain Pathology·Jean-Pierre GagnerDavid Zagzag
Jan 5, 2006·Brain Pathology·Dongyan WangCandece L Gladson
May 12, 2009·International Journal of Cancer. Journal International Du Cancer·Ahlame SaidiSophie Javerzat
Jul 10, 2007·Biochemical and Biophysical Research Communications·Naoki OkaToru Iwama
Jun 11, 2015·PloS One·Hermann B FrieboesVittorio Cristini
Oct 19, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ta-Chiang LiuAndreas Kurtz
Sep 3, 2010·Nonlinearity·J S LowengrubV Cristini
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Florence LefrancRobert Kiss
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vittorio CristiniJohn Sinek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Neoplasia : an International Journal for Oncology Research
J L RubensteinM A Shuman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
V CristiniJohn P Sinek
Expert Opinion on Biological Therapy
Tamara T LahCornelis J F Van Noorden
© 2022 Meta ULC. All rights reserved